• No results found

18 results with keyword: 'sleep benefit in parkinson s disease'

(E) 5 Chloro 3 (2,6 di­chloro­benzyl­­idene)­indolin 2 one

The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are

Protected

N/A

9
0
0
2020
SLEEP AND PARKINSON S DISEASE

Following DBS, some people with Parkinson’s are able to sleep better at night, especially if sleep problems were related to medication wearing off. Most

Protected

N/A

5
0
0
2022
SLEEP AND PARKINSON S DISEASE

• Watch for the common sleep conditions in Parkinson’s disease such as REM sleep behavior disorder, Restless leg syndrome, Insomnia, Obstructive sleep apnea and daytime sleepiness.

Protected

N/A

31
0
0
2022
Quantitative Motor Performance and Sleep Benefit in Parkinson Disease

study, we used these quantitative motor tasks to assess possible changes in motor function after a period of sleep in Parkinson patients.. We compare and describe

Protected

N/A

8
0
0
2021
Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial

Motor function based on the Unified Parkinson ’ s Disease Rating Scale was better in the treatment group, but their scores on sleep and outlook in Parkinson ’ s Disease Quality of

Protected

N/A

11
0
0
2020
Sleep disorders in Parkinson’s disease

Sleep-related problems in PD include insomnia, restless legs syndrome, rapid eye movement sleep behavior disorder, sleep apnea, parasomnias, excessive daytime sleepiness, and

Protected

N/A

6
0
0
2020
Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease

Keywords: Retina, Parkinson ’ s disease, Circadian rhythms, Sleep disorders, Melanopsin retinal ganglion cell,

Protected

N/A

10
0
0
2020
HPC Software Debugger and Performance Tools

Knobloch SC Introduction, November 2015 13 DDT: Main Window Process controls Process groups Source code Variables Expression evaluator Stack trace... DDT:

Protected

N/A

80
0
0
2021
Sleep and Night-time Problems in Parkinson s What are the causes of sleep disruption in Parkinson s? Parkinson s Disease Society

1 Ray Chaudhuri K, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Hogl B, Trenkwalder C. The Parkinson’s disease sleep scale: a new instrument for

Protected

N/A

6
0
0
2021
Home-grown school feeding: promoting local production systems diversification through nutrition sensitive agriculture

More individual foods from the cereals and legumes food groups were included in menus from Northern Ghana, while more individual foods from the tubers, dark, leafy green vegetables

Protected

N/A

9
0
0
2021
Levodopa-induced dyskinesia in Parkinson's disease: sleep matters

ADV = advanced fluctuating patients; AHI = apnea-hypopnea index; AIMS = abnormal involuntary movement scale; CTL = healthy control subjects; DNV = de novo patients; DYS =

Protected

N/A

35
0
0
2021
Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study

PD: Parkinson ’ s disease; MCI: Mild cognitive impairment; PDD: Parkinson ’ s disease with dementia; UPDRS: Unified parkinson ’ s disease rating scale; H & Y: Hoehn and yahr

Protected

N/A

8
0
0
2020
Sleep benefit in Parkinson's disease

However, in our detailed quantitative motor study ( Chapter 5 ) we found no objective motor improvement in patients who reported to experience (subjective) sleep benefit.. This

Protected

N/A

157
0
0
2021
Sleep disturbances in Parkinson's disease patients and management options

Keywords: sleep disorders, insomnia, restless legs syndrome, Parkinson disease, fatigue, REM behavior

Protected

N/A

9
0
0
2020
Drug therapy in patients with Parkinson’s disease

PD: Parkinson ’ s Disease; MAO: Monoaminooxidase; LD: Levodopa; DDI: Dopadecarboxylase inhibitor; TEMPO: a controlled trial of rasagiline in early Parkinson ’ s disease;

Protected

N/A

13
0
0
2020
Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease

PD: Parkinson ’ s disease; CHAPS: Care coordination for health promotion and activities in Parkinson ’ s disease; VA: Veterans health administration; CCM: Chronic care model;

Protected

N/A

13
0
0
2020
Stressful life events and anxiety, depression, and fatigue in people with initial central nervous system demyelination

Given these findings, it was hypothesised that an increased number and severity (including readjustment weighting) of negative stressful life events (but not positive events) would

Protected

N/A

66
0
0
2020
Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease

We surveyed long term changes in subjective reporting of sleep symptoms (nocturnal and daytime) in 40 patients with Parkinson ’ s disease who had Subthalamic Deep Brain

Protected

N/A

6
0
0
2021

Upload more documents and download any material studies right away!